Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T22:47:10.843Z Has data issue: false hasContentIssue false

Penicillins With Antipseudomonal Activity

Published online by Cambridge University Press:  02 January 2015

Sandra M. Norris*
Affiliation:
Department of Medicine, University of Virginia Medical Center, School of Medicine, Charlottesville, Virginia
*
School of Medicine, University of Virginia, Charlottesville, VA 22908

Extract

The escalating role of Pseudomonas aeruginosa as a nosocomial pathogen, the relatively high mortality rate associated with pseudomonal infections, the intrinsic antibiotic resistance of this versatile, ubiquitous organism, and the growing number of reports of multiple antibiotic resistance developing during therapy of Pseudomonas infections prompt a review of currently available penicillins with antipseudomonal activity. Ticarcillin, piperacillin, mezlocillin and azlocillin have upstaged carbenicillin, the first antipseudomonal, β-lactam agent clinically used, with other products “in the wings.”

Information

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable